Genomma Lab Internacional S.A.B. de C.V (LABB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (LABB) has a cash flow conversion efficiency ratio of 0.113x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (MX$1.26 Billion ≈ $72.27 Million USD) by net assets (MX$11.11 Billion ≈ $639.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genomma Lab Internacional S.A.B. de C.V - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read LABB total debt and obligations for a breakdown of total debt and financial obligations.
Genomma Lab Internacional S.A.B. de C.V Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomma Lab Internacional S.A.B. de C.V ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hongsheng Heat Exchanger Mnfg
SHG:603090
|
0.048x |
|
Smartgroup Corporation Ltd
AU:SIQ
|
0.253x |
|
Yuanli Chemical Group Co Ltd
SHG:603217
|
0.010x |
|
Insperity Inc
NYSE:NSP
|
-6.043x |
|
Tianjin Economic-technological Development Area Co Ltd
SHE:000652
|
0.044x |
|
Hunan Jiudian Pharmaceutical Co Ltd
SHE:300705
|
0.068x |
|
CW Enerji SA
IS:CWENE
|
-0.008x |
|
Shenyang Blue Silver Ind Auto
SHE:300293
|
-0.041x |
Annual Cash Flow Conversion Efficiency for Genomma Lab Internacional S.A.B. de C.V (2005–2025)
The table below shows the annual cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Genomma Lab Internacional S.A.B. de C.V worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | MX$11.11 Billion ≈ $639.47 Million |
MX$2.05 Billion ≈ $118.24 Million |
0.185x | -29.37% |
| 2024-12-31 | MX$11.59 Billion ≈ $666.93 Million |
MX$3.03 Billion ≈ $174.59 Million |
0.262x | +39.15% |
| 2023-12-31 | MX$9.38 Billion ≈ $539.98 Million |
MX$1.77 Billion ≈ $101.58 Million |
0.188x | -7.05% |
| 2022-12-31 | MX$10.15 Billion ≈ $584.28 Million |
MX$2.05 Billion ≈ $118.25 Million |
0.202x | +38.83% |
| 2021-12-31 | MX$10.07 Billion ≈ $579.66 Million |
MX$1.47 Billion ≈ $84.50 Million |
0.146x | -18.08% |
| 2020-12-31 | MX$9.63 Billion ≈ $554.45 Million |
MX$1.71 Billion ≈ $98.67 Million |
0.178x | +40.93% |
| 2019-12-31 | MX$7.97 Billion ≈ $458.91 Million |
MX$1.01 Billion ≈ $57.95 Million |
0.126x | -39.97% |
| 2018-12-31 | MX$7.43 Billion ≈ $427.47 Million |
MX$1.56 Billion ≈ $89.92 Million |
0.210x | +6.49% |
| 2017-12-31 | MX$7.05 Billion ≈ $405.65 Million |
MX$1.39 Billion ≈ $80.13 Million |
0.198x | -13.06% |
| 2016-12-31 | MX$6.79 Billion ≈ $390.93 Million |
MX$1.54 Billion ≈ $88.83 Million |
0.227x | +76.83% |
| 2015-12-31 | MX$9.25 Billion ≈ $532.26 Million |
MX$1.19 Billion ≈ $68.39 Million |
0.128x | +29.94% |
| 2014-12-31 | MX$10.50 Billion ≈ $604.46 Million |
MX$1.04 Billion ≈ $59.77 Million |
0.099x | -53.30% |
| 2013-12-31 | MX$8.84 Billion ≈ $508.48 Million |
MX$1.87 Billion ≈ $107.66 Million |
0.212x | +1222.65% |
| 2011-12-31 | MX$5.57 Billion ≈ $320.72 Million |
MX$89.21 Million ≈ $5.13 Million |
0.016x | -92.25% |
| 2010-12-31 | MX$4.11 Billion ≈ $236.63 Million |
MX$849.67 Million ≈ $48.90 Million |
0.207x | +63.53% |
| 2009-12-31 | MX$3.05 Billion ≈ $175.57 Million |
MX$385.52 Million ≈ $22.19 Million |
0.126x | +27.65% |
| 2008-12-31 | MX$2.31 Billion ≈ $133.06 Million |
MX$228.89 Million ≈ $13.17 Million |
0.099x | -43.72% |
| 2007-12-31 | MX$587.44 Million ≈ $33.81 Million |
MX$103.33 Million ≈ $5.95 Million |
0.176x | +59.27% |
| 2005-12-31 | MX$164.93 Million ≈ $9.49 Million |
MX$18.21 Million ≈ $1.05 Million |
0.110x | -- |
About Genomma Lab Internacional S.A.B. de C.V
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products t… Read more